Sold
Available
IBL-26-0424

Method for measuring fibrinogen concentration in blood samples and nanoparticles for the same

Listed on
2026-07-03
Nanoparticle-based method for enzyme-free measurement of fibrinogen concentration in blood

This technology concerns a method for measuring the concentration of fibrinogen protein in human blood samples and nanoparticles for this purpose.

Conventional fibrinogen measurement methods had significant limitations, such as large errors and long processing times, stemming from enzyme activity effects and the need for reference plasma measurements.

This technology is convenient as it does not use enzymes, eliminates errors caused by enzyme activity factors, and reduces measurement time by eliminating the need for reference measurements. Consequently, it offers superior accuracy, precision, and reproducibility compared to existing methods.

Key Features:
  • Nanoparticles for measuring fibrinogen concentration in blood samples
  • Simple, enzyme-free measurement method
  • Reduced measurement time without reference plasma measurement
  • Achieves superior accuracy, precision, and reproducibility
Korea University
Kim In-soo | Kwon Do-hyung | Lee Dong-taek | Lee Sang-won | Lee Gyu-bok | Lee Gyu-do | Yoon Dae-sung
Document
Date of application:
2018-04-17
|
Patent registration number:
10-2094241
Industry
bio
Technology
Medical devices
Country
Korea
United States
Family Patent

US2021-0116448A1

Price
가격협의
Subscribe to our newsletter to receive the latest patent information faster than anyone else.
← Back to list